Compare Novartis with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TTK HEALTHCARE - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TTK HEALTHCARE NOVARTIS/
TTK HEALTHCARE
 
P/E (TTM) x 479.2 17.3 2,769.3% View Chart
P/BV x 27.8 1.4 2,006.1% View Chart
Dividend Yield % 1.6 1.1 147.5%  

Financials

 NOVARTIS   TTK HEALTHCARE
EQUITY SHARE DATA
    NOVARTIS
Mar-18
TTK HEALTHCARE
Mar-19
NOVARTIS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs7581,215 62.4%   
Low Rs579610 94.9%   
Sales per share (Unadj.) Rs228.4444.4 51.4%  
Earnings per share (Unadj.) Rs31.717.2 184.0%  
Cash flow per share (Unadj.) Rs32.827.6 118.6%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Dividend yield (eoy) %1.50.5 273.0%  
Book value per share (Unadj.) Rs297.1177.9 167.0%  
Shares outstanding (eoy) m24.6914.13 174.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.92.1 142.5%   
Avg P/E ratio x21.152.9 39.8%  
P/CF ratio (eoy) x20.433.0 61.8%  
Price / Book Value ratio x2.25.1 43.9%  
Dividend payout %31.529.0 108.7%   
Avg Mkt Cap Rs m16,50512,894 128.0%   
No. of employees `0000.72.3 28.9%   
Total wages/salary Rs m1,4451,307 110.6%   
Avg. sales/employee Rs Th8,441.32,715.7 310.8%   
Avg. wages/employee Rs Th2,163.6565.3 382.7%   
Avg. net profit/employee Rs Th1,173.1105.4 1,112.9%   
INCOME DATA
Net Sales Rs m5,6396,279 89.8%  
Other income Rs m1,71878 2,217.2%   
Total revenues Rs m7,3576,356 115.7%   
Gross profit Rs m-63496 -12.6%  
Depreciation Rs m25147 17.2%   
Interest Rs m5534 163.6%   
Profit before tax Rs m1,575393 401.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m792149 531.6%   
Profit after tax Rs m784244 321.5%  
Gross profit margin %-1.17.9 -14.0%  
Effective tax rate %50.337.9 132.5%   
Net profit margin %13.93.9 358.0%  
BALANCE SHEET DATA
Current assets Rs m9,5222,717 350.4%   
Current liabilities Rs m3,2961,571 209.8%   
Net working cap to sales %110.418.3 604.7%  
Current ratio x2.91.7 167.0%  
Inventory Days Days3732 113.9%  
Debtors Days Days2847 60.9%  
Net fixed assets Rs m46991 4.6%   
Share capital Rs m123141 87.3%   
"Free" reserves Rs m7,2132,373 304.0%   
Net worth Rs m7,3362,514 291.8%   
Long term debt Rs m03 0.0%   
Total assets Rs m11,1054,158 267.1%  
Interest coverage x29.512.6 233.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.51.5 33.6%   
Return on assets %7.66.7 113.2%  
Return on equity %10.79.7 110.2%  
Return on capital %22.216.9 131.2%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m61225 26.9%   
Fx outflow Rs m3,63071 5,105.0%   
Net fx Rs m-3,570154 -2,316.6%   
CASH FLOW
From Operations Rs m1,610173 930.0%  
From Investments Rs m68797 711.9%  
From Financial Activity Rs m-2,677-307 871.0%  
Net Cashflow Rs m-380-38 1,006.9%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 3.7 54.1%  
FIIs % 1.6 5.2 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.8 83.3%  
Shareholders   41,647 12,723 327.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   IPCA LABS  GSK PHARMA  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  SANOFI INDIA  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 18, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS